Results 101 to 110 of about 3,683 (169)

Role of Biomarkers in Diagnosing Disease, Assessing the Severity and Progression of Disease, and Evaluating the Efficacy of Therapies. [PDF]

J Inherit Metab Dis
Schiffmann R.
europepmc   +1 more source

Dapagliflozin in Patients With CKD With Fabry Disease. [PDF]

Kidney Int Rep
Battaglia Y, Vitturi N, Marchi G, Baciga F, Caccia F, Gugelmo G, Martinetti L, Stefanelli LF, Torresani S, Pisani A, Riccio E, Esposito P, Viazzi F, Chimenti C, Martino FK, Lenzini L, Sechi A, Zanoli L, Girelli D, Fadini GP, Nalesso F, Carraro G.   +21 more
europepmc   +1 more source

Correction: Globotriaosylceramide Accumulation and Not Alpha-Galactosidase-A Deficiency Causes Endothelial Dysfunction in Fabry Disease.

PLoS ONE, 2012
Mehdi Namdar, Catherine Gebhard, Rafael Studiger, Yi Shi, Pavani Mocharla, Christian Schmied, Pedro Brugada, Thomas F. Lüscher, Giovanni G. Camici   +8 more
doaj   +1 more source

Cutaneous leukocytoclastic vasculitis as a nonclassical presentation of Fabry disease in an adult female patient. [PDF]

JAAD Case Rep
Vo C, Solway J.
europepmc   +1 more source

Spinal anesthesia in a patient with Fabry disease and multiorgan involvement: a rare case with long-term success. [PDF]

Am J Transl Res
Kim HT, Bae JH, Shin YD, Park JW, Jeong SJ, Lee JY.   +5 more
europepmc   +1 more source

Systemic metabolic reprogramming and microbial dysbiosis in Fabry disease: Multi-omics mechanisms and implications for drug development. [PDF]

Front Pharmacol
Gómez-Cebrián N, Trull MC, Gras-Colomer E, Edo Solsona MD, Poveda Andrés JL, Puchades-Carrasco L.   +5 more
europepmc   +1 more source

Misprocessing of α -Galactosidase A, Endoplasmic Reticulum Stress, and the Unfolded Protein Response. [PDF]

J Am Soc Nephrol
Živná M, Živná M, Dostálová G, Barešová V, Mušálková D, Svojšová K, Meiseles D, Kinstlinger S, Kuchař L, Asfaw B, Poupětová H, Vlášková H, Kmochová T, Vyleťal P, Hartmannová H, Hodaňová K, Stránecký V, Steiner-Mrázová L, Hnízda A, Živný J, Radina M, Votruba M, Sovová J, Trešlová H, Stolnaja L, Reková P, Roblová L, Honsová E, Rychlík I, Dvela-Levitt M, Bleyer AJ, Linhart A, Sikora J, Kmoch S.   +33 more
europepmc   +1 more source

How should kidney injury in Fabry disease be assessed and monitored? [PDF]

Kidney Res Clin Pract
Song SH.
europepmc   +1 more source

Nanomedicines for DNA and interference RNA co-delivery: Combined gene therapy for Fabry disease. [PDF]

Int J Pharm X
Beraza-Millor M, Fernández-Muro P, Arribas-Galarreta M, Del Pozo-Rodríguez A, Rodríguez-Gascón A, Solinís MÁ.   +5 more
europepmc   +1 more source

The Role of Kidney Biopsy in Fabry Disease. [PDF]

Biomedicines
Capelli I, Martano L, Berti GM, Vischini G, Lerario S, Donadio V, Incensi A, Aiello V, Ciurli F, Fabbrizio B, Chilotti S, Mignani R, Pasquinelli G, La Manna G.   +13 more
europepmc   +1 more source